AVITA Medical

AVITA Medical is a therapeutic acute wound care company specializing in innovative technologies for thermal burn wounds, trauma wounds, surgical wounds, and full-thickness skin defects. The company's flagship product is the RECELL® System, an FDA-approved device that uses a small sample of the patient's own skin to create a suspension of Spray-On Skin™ Cells, prepared and applied at point-of-care. RECELL has been approved by the FDA for thermal burn wounds and full-thickness skin defects. AVITA Medical also holds exclusive US marketing, sales, and distribution rights for PermeaDerm®, a biosynthetic wound matrix dressing that adheres in a single application, and Cohealyx™, a collagen-based dermal matrix for full-thickness wound management. The company markets these products as optimizing wound healing and accelerating patient recovery times. AVITA Medical maintains certification to the AdvaMed U.S. Code of Ethics. The company has a robust pipeline exploring additional skin-related indications using its patented cellular technology platform. Recent announcements indicate FDA approval of the RECELL GO System and a 10-year BARDA agreement valued at $25.5 million for product development and supply.